Skip to main content

News & Events

Updates about Leica Biosystems.

39901-Aperio-GT-450-DX-Scanner-640x410-Banner
Published: 23 April 2024

Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due to the COVID-19 pandemic, Aperio GT 450 is…

csm_Leica_Biosystems
Published: 9 November 2023

Leica Biosystems enables researchers to accelerate their journey, transforming scientific exploration into translational outcomes, with a new digital pathology software release.. VISTA, CA – Leica Biosystems, a global leader in pathology workflow solutions, is pleased to announce the release of…

csm_Leica_Biosystems
Published: 26 October 2023

ORLANDO, FL – Leica Biosystems, a global leader in anatomic pathology, and Paige, a leader in digital pathology software and diagnostic AI applications, previously announced a partnership to create an integrated solution, to expand access to accelerate adoption of digital pathology and artificial…

csm_Leica_Biosystems
Published: 9 June 2023

Leica Biosystems new dual detection kit enables clinicians to get more information out of their tissue samples. NEWCASTLE, UK - Leica Biosystems is pleased to announce the launch of BOND ChromoPlex II Dual Detection, a plug-and-play dual detection system designed to deliver IHC and ISH dual…

csm_Leica_Biosystems
Published: 3 April 2023

The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…

csm_Leica_Biosystems
Published: 13 March 2023

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems,…

csm_Leica_Biosystems
Published: 9 December 2022

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head on – from company founder Rudolf Jung building the first microtome to today’s world-leading Digital Pathology empowering AI development. No other global company…